Conversely, the combination of budesonide and Poractant Alfa injection reduces the hyperoxia-induced increase in SENP1 in peripheral blood mononuclear cells of preterm infants, which mitigates the nucleoplasmic shuttling of SIRT1 and ultimately prevents BPD (71). This evidence concerns the gene SIRT1 and bronchopulmonary dysplasia.